SecBot SecBot
PRESS-RELEASE ·Filed Oct 13, 2026

INMD

InMode Ltd.
NEUTRAL
Impact 5/10
Horizonweeks Processed13d 18h ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

The pre-announcement shows in-line to slightly better revenue, but the lack of an earnings call and ongoing strategic review creates uncertainty. Watch for any update on the strategic proposal, which could be a catalyst for a takeout premium or a failed process risk.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+5d
INMD ▼ -1.15% at T+5d
NEUTRAL call -1.15% · α vs SPY -0.00% · entry $14.31 → $14.14
Next anchor: T+20d in 14d
Latest observation: T+8 -1.74% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
-0.17%
call -0.17% · α +0.91%
$14.28
settled 13d ago
T+5d
-1.15%
call -1.15% · α -0.00%
$14.14
settled 7d ago
T+20d
Pending
in 14d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

InMode pre-announced Q3 2026 revenue of $91.8M-$92.0M, slightly above the $91.6M consensus, and reiterated FY 2026 guidance of $365M-$375M. The company also disclosed that its Special Committee continues to evaluate a strategic proposal and will not host an earnings call, adding uncertainty around the strategic review outcome.

Key Financial Metrics

EPS
$0.35
est $0.32 · +8.7%
Revenue
$91.8M
est $91.6M · +0.2%
Rating
in line
Guidance
$91.8M-$92.0M (Q3), $365M-$375M (FY)
maintained

Key Facts

  • Q3 2026 preliminary revenue guidance: $91.8M-$92.0M vs consensus $91.6M
  • FY 2026 revenue guidance reiterated at $365M-$375M
  • EPS for Q2 2026 was $0.35, beating consensus of $0.32 by 8.7%
  • Special Committee continues evaluating a strategic proposal
  • No investor conference call or webcast will be held for Q3 2026 earnings
  • Results are preliminary and subject to final adjustments

Financial Impact

Q3 revenue slightly above consensus by ~0.2%-0.4%; full-year guidance unchanged

revenueeps

Risk Factors

  • Strategic proposal may not lead to a transaction, creating downside if expectations were high
  • Preliminary results subject to final adjustments
  • No earnings call limits visibility into underlying trends and margins

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302906038
11 reports for INMD
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +7.66%Jul 13, 2026
Filters
Rows
Reports for INMD — sortable, filterable
TypeNow
Oct 26, 2026
today
6-K
NEUTRAL ★ 3/10
$14.16awaiting T+20—$13.72 (−3.11%)
Oct 21, 2026
5d ago
SC 13D/A
NEUTRAL ★ 4/10
$14.03awaiting T+20—$13.72 (−2.21%)
Oct 13, 2026
13d ago
Press Release
NEUTRAL ★ 5/10
$14.31awaiting T+20—$13.72 (−4.09%)
Sep 16, 2026
5w ago
6-K
BEARISH ★ 6/10
$14.58 $14.31▲ +1.89%▲ +5.06%$13.72 (+5.90%)
Aug 5, 2026
11w ago
6-K
BEARISH ★ 6/10
$15.21 $14.95▲ +1.71%▲ +1.11%$13.72 (+9.80%)
Aug 3, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$15.35 $14.96▼ −2.54%▼ −3.78%$13.72 (−10.62%)
Jul 20, 2026
14w ago
6-K
BULLISH ★ 6/10
$15.36 $14.99▼ −2.41%▼ −4.97%$13.72 (−10.68%)
Jul 13, 2026
15w ago
6-K
BEARISH ★ 6/10
$15.15 $15.19▼ −0.26%▲ +2.92%$13.72 (+9.44%)
Jul 10, 2026
15w ago
6-K
BULLISH ★ 7/10
$15.28 $15.31▲ +0.20%▼ −2.23%$13.72 (−10.21%)
Jun 25, 2026
17w ago
6-K
BEARISH ★ 6/10
$14.63 $15.09▼ −3.14%▼ −1.88%$13.72 (+6.22%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 8h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026